$0.96
4.27%
Nasdaq, Nov 28, 08:10 pm CET
ISIN
IL0011651580
Symbol
PRFX

PainReform Ltd Stock price

$0.96
-0.35 26.37% 1M
-0.99 50.54% 6M
-2.39 71.25% YTD
-1.79 64.93% 1Y
-114.24 99.16% 3Y
-1,158.24 99.92% 5Y
-1,616.64 99.94% 10Y
-1,616.64 99.94% 20Y
Nasdaq, Closing price Fri, Nov 28 2025
+0.04 4.27%
ISIN
IL0011651580
Symbol
PRFX
Industry

Key metrics

Basic
Market capitalization
$1.9m
Enterprise Value
$-1.5m
Net debt
positive
Cash
$3.5m
Shares outstanding
2.0m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
- | -
EV/Sales
- | -
EV/FCF
0.3
P/B
0.2
Financial Health
Equity Ratio
40.3%
Return on Equity
-799.8%
ROCE
-195.9%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$0.0 | $0.0
EBITDA
$-16.9m | -
EBIT
$-17.0m | $-26.3m
Net Income
$-16.9m | $-98.9m
Free Cash Flow
$-6.0m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
5.2% | -
EBIT
4.4% | -79.5%
Net Income
4.4% | -577.9%
Free Cash Flow
47.7%
Margin (TTM | estimate)
Gross
-
EBITDA
- | -
EBIT
-
Net
- | -
Free Cash Flow
-
More
EPS
$-8.0
FCF per Share
$-3.0
Short interest
6.1%
Employees
4
Rev per Employee
$0.0
Show more

Is PainReform Ltd a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,070 stocks worldwide.

PainReform Ltd Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a PainReform Ltd forecast:

3x Hold
50%
3x Sell
50%

Analyst Opinions

6 Analysts have issued a PainReform Ltd forecast:

Hold
50%
Sell
50%

Financial data from PainReform Ltd

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 4.89 4.89
59% 59%
-
- Research and Development Expense 12 12
19% 19%
-
-17 -17
5% 5%
-
- Depreciation and Amortization 0.17 0.17
750% 750%
-
EBIT (Operating Income) EBIT -17 -17
4% 4%
-
Net Profit -17 -17
4% 4%
-

In millions USD.

Don't miss a Thing! We will send you all news about PainReform Ltd directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

PainReform Ltd Stock News

Neutral
GlobeNewsWire
18 days ago
TEL AVIV, Israel, Nov. 12, 2025 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) today announced that DeepSolar, its solar energy business unit developing next-generation AI analytics, has advanced the development of its proprietary automated reporting engine, designed to transform how solar-asset performance is analyzed, understood, and communicated.
Neutral
GlobeNewsWire
25 days ago
TEL AVIV, Israel, Nov. 05, 2025 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX), today announced that DeepSolar, its solar energy business unit developing next-generation AI-driven solar analytics, was recently featured in a Watchlist Interview produced in collaboration with The Market Link, highlighting its participation in the NVIDIA Connect program.
Neutral
GlobeNewsWire
2 months ago
TEL AVIV, Israel, Oct. 01, 2025 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX), a specialty pharmaceutical company focused on the reformulation of established therapeutics and commercialization of AI-driven solar analytics technologies, today provided a business update for the six months ended June 30, 2025.
More PainReform Ltd News

Company Profile

PainReform Ltd. operates as a pharmaceutical company. It develops and markets pharmaceuticals. The firm focuses on developing reformulation of pain therapeutics, PainReform applies its propriety formulation technologies to prolong and enhance efficacy, reduce adverse effects shortening recovery time and reduce the need of augmentation with drugs such as opioids and NSAIDS. The company was founded by Lihu Avitov and Dan Teleman in 2007 and is headquartered in Herzliya, Israel.

Head office Israel
CEO Ehud Geller
Employees 4
Founded 2007
Website painreform.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today